Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy
Urologic Oncology: Seminars and Original Investigations | Dec 04, 2017
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy
International Journal of Experimental Pathology | Dec 03, 2017